| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 10.987 | 50.465 | 61.620 | 78.218 |
| Total Income - EUR | - | - | - | - | - | - | 10.987 | 53.811 | 61.721 | 78.996 |
| Total Expenses - EUR | - | - | - | - | - | - | 1.046 | 14.639 | 24.220 | 35.525 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 9.941 | 39.171 | 37.501 | 43.471 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 9.618 | 37.948 | 36.897 | 42.705 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Raidavderm S.r.l.-D.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 23.094 | 16.195 | 10.096 |
| Current Assets | - | - | - | - | - | - | 9.755 | 35.939 | 76.867 | 121.859 |
| Inventories | - | - | - | - | - | - | 7 | 1.176 | 3.633 | 1.410 |
| Receivables | - | - | - | - | - | - | 0 | 0 | 123 | 67.061 |
| Cash | - | - | - | - | - | - | 9.749 | 34.763 | 73.112 | 53.387 |
| Shareholders Funds | - | - | - | - | - | - | 9.618 | 47.596 | 84.349 | 126.583 |
| Social Capital | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Debts | - | - | - | - | - | - | 323 | 11.436 | 8.714 | 5.373 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Raidavderm S.r.l.-D.